Candidate HDACi drug effects of SAHA, VPA and CI994 at 48 hours revealed that except for the CI994 in thyroid cancer cell lines, all other non-breast cancer cell lines showed significant increase in NIS promoter activity (Supplementary Fig. 3B). Here, SLC5A5 is linked to thyroid gland carcinoma.